![]() | |
公司名 | BOC Sciences |
联系人 | Linna Green |
电 话 | +16314854226 |
手 机 | +16314854226 |
电子邮件 | info@bocsci.com |
网 址 | https://www.bocsci.com/ |
地 区 | 其他 |
邮 编 | 11967 |
在线询盘仅适合非紧急采购的情形,您需要留下收货地域,采购数量及联系方式。供应商在收到您的询盘信息后,会通过您留下的联系方式联络您。如果您希望立即和供应商交谈,请直接拨打供应商电话。供应商手机:+16314854226
中文名 | SCH772984 |
英文名 | SCH772984 |
别名 | ERK1和ERK2活性抑制剂(SCH772984) (R)-1-(2-氧代-2-(4-(4-(2-嘧啶L)苯基)-L-哌嗪)乙基)-3-[N- 1-(2-氧代-2-(4-(4-(嘧啶-2-基)苯基)哌嗪-1-基)乙基)吡咯烷-3-甲酸(R)-甲酯 (R)-1-(2-氧代-2-(4-(4-(2-嘧啶L)苯基)-L-哌嗪)乙基)-3-[N-(3-(4-吡啶)吲唑-5-氨基]甲酰基-吡咯烷 |
CAS | 942183-80-4 |
EINECS | 1592732-453-0 |
化学式 | C33H33N9O2 |
分子量 | 587.67 |
inchi | |
包装信息 | 25 mg |
价格 | $498 |
产品描述 | SCH772984 SCH772984 is a potent and selective ERK inhibitor with potential anticancer activity. SCH722984 showed activity against BRAF mutant, NRAS mutant and wild-type melanoma. Combining vemurafenib and SCH722984 in BRAF mutant melanoma was synergistic in a majority of cell lines and significantly delayed the onset of acquired resistance in long term in vitro assays. Therefore, SCH772984 may be clinically applicable as a treatment for non-BRAF mutant melanoma or in BRAF-mutant melanoma with innate or acquired resistance, alone or in combination with BRAF inhibitors. |
产品链接 | https://www.bocsci.com/product/sch772984-cas-942183-80-4-429803.html |
更新日期 | 2025-04-30 11:27:47 |